Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
02/21/1996 | EP0697414A1 Compounds and methods for inhibiting propagation of human immunodeficiency virus |
02/21/1996 | EP0697412A1 Benzoxazolyl- and benzo-thiazolyl-oxazolidinones |
02/21/1996 | EP0697408A1 1 substituted-phenyl-oxazolidene-2-one derivatives and their use as adhesion-receptor antagonists |
02/21/1996 | EP0697405A1 Substituted quinoline derivatives, process for their preparation and their use |
02/21/1996 | EP0697015A1 Optically active 3-(1-(alkylamino))alkyl pyrrolidines |
02/21/1996 | EP0560795B1 38-decarboxy-38-hydroxymethyl derivatives of teicoplanin antibiotics, and a process for preparing them |
02/21/1996 | EP0516785B1 RECOMBINANT ANTIBODIES SPECIFIC FOR TNF alpha |
02/21/1996 | CN1117291A 4-hydroxy-benzopyran-2-ones and 4-hydroxy-cycloalkyl|B¨pyran-2-ones useful to treat retroviral infections |
02/21/1996 | CN1116932A Biological bacteriostat and its preparing method |
02/21/1996 | CN1031058C Antiviral tetrahydroimidazo |1,4¨-benzodiazepin-2-ones derivatives |
02/21/1996 | CN1031054C Process for production of bis-(hydroxymethyl)-cyclobutyl-purines and pyrimidines |
02/20/1996 | US5493018 Process for synthesizing carbapenem intermediates using a rhodium catalyst and lewis acid |
02/20/1996 | US5493017 Ring-metalated porphyrins |
02/20/1996 | US5492918 Use of substituted chromans, some of which are known, as medicaments, new active compounds and processes for their preparation |
02/20/1996 | US5492896 Pseudopeptides having an antiviral action |
02/20/1996 | US5492889 Treatment of mast cell tumors |
02/20/1996 | US5492689 Administering simultaneously an antiviral agent and two antiinflammatory compounds; synergistic result in treatment of cold or influenza |
02/20/1996 | US5492314 Preloaded digressive rate mount |
02/18/1996 | CA2156120A1 3-substituted-2-oxindoles as inhibitors of viral replication |
02/17/1996 | CA2156128A1 Substituted quinoline derivatives, a process for their preparation, and their use |
02/15/1996 | WO1996004386A1 Method of using transdominant negative retroviral integrase in the treatment of retroviral infection |
02/15/1996 | WO1996004385A2 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use |
02/15/1996 | WO1996004384A1 Identification of a human cytomegalovirus gene involved in down-regulation of mhc class i heavy chain expression |
02/15/1996 | WO1996004383A1 Identification of a human cytomegalovirus gene region involved in down-regulation of mhc class i heavy chain expression |
02/15/1996 | WO1996004378A2 Chimeric proteins and muteins of tissue factor pathway inhibitors tfpi and tfpi-2 |
02/15/1996 | WO1996004299A1 Streptogramine derivatives, preparation of same and pharmaceutical compositions containing same |
02/15/1996 | WO1996004298A1 Purified form of streptogramines, preparation of same and pharmaceutical compositions containing same |
02/15/1996 | WO1996004295A1 5'-dithio-modified oligonucleotides |
02/15/1996 | WO1996004286A1 Process for making quinolonyl lactam antimicrobials and novel intermediate compounds |
02/15/1996 | WO1996004285A1 6β-SUBSTITUTED PENICILLANIC ACIDS AS β-LACTAMASE INHIBITORS |
02/15/1996 | WO1996004263A1 Method for the preparation of (±)-calanolide a and intermediates thereof |
02/15/1996 | WO1996004257A1 Crystalline form of an antifungal azole |
02/15/1996 | WO1996004250A1 Benzimidazole derivatives having dopaminergic activity |
02/15/1996 | WO1996004247A1 Process for making antimicrobial compounds |
02/15/1996 | WO1996004242A1 Arylthio compounds as antibacterial and antiviral agents |
02/15/1996 | WO1996004010A1 Vr-2332 viral nucleotide sequence and methods of use |
02/15/1996 | WO1996003883A1 Cells bearing cd4 decoy receptors and related molecules and methods |
02/15/1996 | WO1996003876A1 Method for inhibiting nucleoside and nucleobase transport and virus replication in mammalian cells |
02/15/1996 | DE3891231C2 Astigmatism correcting laser surgical set |
02/15/1996 | CA2328638A1 Identification of a human cytomegalovirus gene involved in down-regulation of mhc class i heavy chain expression |
02/15/1996 | CA2196450A1 Purified form of streptogramines, preparation of same and pharmaceutical compositions containing same |
02/15/1996 | CA2196290A1 Chimeric proteins and muteins of tissue factor pathway inhibitors tfpi and tfpi-2 |
02/15/1996 | CA2196102A1 Streptogramine derivatives, preparation of same and pharmaceutical compositions containing same |
02/15/1996 | CA2195864A1 5'-dithio-modified oligonucleotides |
02/15/1996 | CA2195430A1 6.beta.-substituted penicillanic acids as .beta.-lactamase inhibitors |
02/15/1996 | CA2195312A1 Novel hepatitis c e1 and e2 truncated polypeptides and methods of obtaining the same |
02/15/1996 | CA2194567A1 Crystalline form of an antifungal azole |
02/15/1996 | CA2194488A1 Method of using transdominant negative retroviral integrase in the treatment of retroviral infection |
02/15/1996 | CA2193845A1 Arylthio compounds as antibacterial and antiviral agents |
02/15/1996 | CA2172830A1 Method for inhibiting nucleoside and nucleobase transport and virus replication in mammalian cells |
02/15/1996 | CA2172273A1 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use |
02/14/1996 | EP0696640A2 Recombinant antigen from the NS3 region of hepatitis C virus |
02/14/1996 | EP0696287A1 Ureido derivatives of naphthalenephosphonic acids and process for their preparation |
02/14/1996 | EP0696277A1 Hiv protease inhibitors useful for the treatment of aids |
02/14/1996 | EP0696275A1 Vitamin d amide derivatives |
02/14/1996 | EP0696202A1 Pharmaceutical composition containing thymoctonan and azt |
02/14/1996 | EP0696201A1 Supplemented and unsupplemented tissue sealants, methods of their production and use |
02/14/1996 | CN1116849A Process for the manufacture of a tricyclic compound |
02/14/1996 | CN1116628A Cyclopeptides of the formulal |
02/14/1996 | CN1116536A Chinese medicinal herb preparation for prevention and treatment of poultry and animal diseases |
02/14/1996 | CN1030964C Task-masking composition of bitter pharmaceutical agents |
02/13/1996 | US5491231 Hindered N-oxide esters of rapamycin |
02/13/1996 | US5491229 Rapamycin derivative |
02/13/1996 | US5491166 Inhibitors of HIV protease useful for the treatment of AIDS |
02/13/1996 | US5491128 Aglycons of A/16686 antibiotics |
02/13/1996 | US5491073 Cloning of chicken anaemia DNA |
02/13/1996 | US5490498 Adding fluorocarbon along with breathing gas which oxygenates the fluorocarbon; treatment of respiratory distress syndrome |
02/13/1996 | CA2090422C Pharmaceutical composition of florfenicol |
02/09/1996 | CA2155496A1 Nucleic acid-binding oligomers for therapy and diagnosis |
02/08/1996 | WO1996003510A1 A polynucleotide herpes virus vaccine |
02/08/1996 | WO1996003430A1 Organic compounds |
02/08/1996 | WO1996003415A1 Human potassium channel 1 and 2 proteins |
02/08/1996 | WO1996003407A1 Compounds useful as antiproliferative agents and garft inhibitors |
02/08/1996 | WO1996003406A1 Compounds useful as antiproliferative agents and garft inhibitors |
02/08/1996 | WO1996003383A1 INDOLIZINE sPLA2 INHIBITORS |
02/08/1996 | WO1996003382A1 Monomeric and dimeric naphthylisoquinoline alkaloids and synthesis methods thereof |
02/08/1996 | WO1996003381A1 Dimeric arylisoquinoline alkaloids and synthesis methods thereof |
02/08/1996 | WO1996003376A1 1H-INDOLE-1-FUNCTIONAL sPLA2 INHIBITORS |
02/08/1996 | WO1996003152A1 Antisense oligonucleotides against hepatitis b viral replication |
02/08/1996 | WO1996003142A1 Drug delivery composition for the nasal administration of antiviral agents |
02/08/1996 | WO1996003140A1 HLA binding peptides and their uses |
02/08/1996 | WO1996003135A1 Pharmaceutical compositions, mainly vaginal suppository, containing many different active ingredients |
02/08/1996 | WO1996003126A1 Method of treating opportunistic infections with azaspiranes |
02/08/1996 | WO1996003123A1 Methods |
02/08/1996 | WO1996003120A1 INDENE sPLA2 INHIBITORS |
02/08/1996 | DE4427530A1 New 7-tri:cyclic amino-quinolone or naphthyridone derivs |
02/08/1996 | CA2196070A1 Antisense oligonucleotides against hepatitis b viral replication |
02/08/1996 | CA2195778A1 Method of treating opportunistic infections with azaspiranes |
02/08/1996 | CA2195671A1 Hla binding peptides and their uses |
02/08/1996 | CA2195647A1 Monomeric and dimeric naphthylisoquinoline alkaloids and synthesis methods thereof |
02/08/1996 | CA2195646A1 Dimeric arylisoquinoline alkaloids and synthesis methods thereof |
02/08/1996 | CA2195639A1 Drug delivery composition for the nasal administration of antiviral agents |
02/08/1996 | CA2195570A1 Indolizine spla2 inhibitors |
02/08/1996 | CA2195569A1 1h-indole-1-functional spla2 inhibitors |
02/08/1996 | CA2195432A1 Indene spla2 inhibitors |
02/08/1996 | CA2195420A1 Compounds useful as antiproliferative agents and garft inhibitors |
02/08/1996 | CA2195099A1 A polynucleotide herpes virus vaccine |
02/07/1996 | EP0695803A2 Epitopic regions of pneumococcal surface protein A |
02/07/1996 | EP0695548A1 A stably storable and readily water soluble composition of cephalosporin for injections |
02/07/1996 | EP0695357A1 Mammal cell lines and method of obtaining glycoproteins |